4 Takeaways From The FDA's Info-Sharing Guidance
The U.S. Food and Drug Administration recently released finalized guidance loosening restrictions on what information drug and medical device companies can share with insurers and other third-party payors, a development attorneys...To view the full article, register now.
Already a subscriber? Click here to view full article